Navigation Links
China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
Date:5/22/2008

TAIAN CITY, Shandong, China, May 22 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (''CBP,'' or ''the Company''), one of the leading plasma-based pharmaceutical companies in the People's Republic of China (''PRC''), today announced that the Company received approval from the Bureau of Health in Guangxi Province (1) to relocate its Fang Cheng Plasma Collection Station to a more favorable location with a wider coverage area and (2) to purchase excess clinical plasma from six other central plasma stations in Guangxi.

Approval to relocate Fang Cheng Plasma Collection Station

The Fang Cheng Plasma Collection Station, currently located in Fang Cheng Gang City, Guangxi Province, has the lowest plasma collection volume among all seven CBP collection stations, primarily due to its location and coverage area. As a result of the approval, the Company may relocate the station elsewhere within Fang Cheng Gang City, or within Qin Zhou City or Bei Hai City. Management has started the search and evaluation process in order to find the best location for the station. Management expects that relocating the station would greatly increase the station's plasma collection volume in the future.

Approval to purchase excess clinical plasma

Excess clinical plasma is an important source of raw materials for plasma- based pharmaceutical companies, especially in light of China's severe shortage of plasma supply.

With the approval, CBP can purchase excess clinical plasma from the Central Plasma Stations in six cities of Guangxi Province, including Bai Se, Yu Lin, Lai Bin, Qin Zhou, Fang Cheng Gang and He Zhou. To date, the Company has signed contracts with four of these six stations and has procured three tons of excess clinical plasma.

''We are pleased to receive the approval from the Bureau of Health in Guangxi Province,'' said Mr. Stanley Wong, the Company's CEO. ''It is very helpful to expand our plasm
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...smart Now the Only Provider to Offer Practice Mana...zes and Types of Mental Health Care Providers, GR...nc.,a leading provider of enterprise-wide software...ale VantageMed,Corporation, a subsidiary of Nighti...
...dings suggest treatment ,holidays, improve quality...(HealthDay News) -- Some men with advanced prostat..., says a study by researchers at the Oregon Health... from the prostate and isn,t affected by the male ...
... COLD SPRING HARBOR, N.Y. Rarely has a book in ...odor Boveris 1914 monograph Concerning the Origin...nd previously almost impossible to track down, the...Concerning the Origin of Malignant Tumours had a ...
...HELL, Wash., Feb. 29 Nastech,Pharmaceutical Compa...ill,host a conference call with investors and secu...m. Eastern time (8:30 a.m. Pacific time) to,discus...901-5259 and international callers should dial (61...
...PHIS, Tenn., Feb. 29 Smith & Nephew,Inc.,s (NYSE:... Business Unit,announced today the appointment of ...ral manager for its business in Asia and Australia...ion, marketing and supply., Durniak,s appointment...
... these side effects are rare and benefits still ou... 29 (HealthDay News) -- Cholesterol-lowering stati...h researchers report. , However, "our series sugge...y Hospital. , Reporting in the March issue of Art...
Other Medicine News:Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 2Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 3Health News:Netsmart Technologies Acquires Largest Provider of Software for Private Practice Mental Health Providers and Therapists 4Health News:Chemo Break Benefits Some Men With Prostate Cancer 2Health News:Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 2Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 3Health News:Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced 4Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 2Health News:Cholesterol-Lowering Statins Tied to Tendon Woes 3
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...GEWATER, N.J., Nov. 25 The FDA gra...avirine) tablets, a non-nucleoside reverse transcr...RTI specifically indicated for use in treatment-ex...ilure with HIV-1 strains resistant to an NNRTI and...al approval is based on 48-week data from two Phas...
(Date:11/25/2009)...SKING RIDGE, N.J., Nov. 25 Regado ...development of antithrombotic aptamers with active...CEO and President, will be presenting at the Piper... New York Palace Hotel in New York City. Dr. Mazz...Tuesday, December 1 and will include an overview o...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Electrocardiogram Blip Signals Heart Trouble 49820 1Electrocardiogram Blip Signals Heart Trouble 49820 2Electrocardiogram Blip Signals Heart Trouble 49820 3Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 1Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 2Connextions Inc Strengthens Technology Capabilities with Addition of Highly Regarded IT Executive 49816 3Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 1Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 2Children 26apos 3Bs National Medical Center Honors The Children 26apos 3Bs Cancer Foundation for Commitment to Area Kids 49812 3
...ppoints Director, Clinical Operations and Manager,...tar LLC, (Cellectar), a,privately-held radiopharma...ts to detect, treat and monitor human cancers, tod...rector, Clinical Operations and LisaAnn,Trembath a...eflect the,advancement of the company,s lead produ...
...NCETON, N.J., Oct. 3 Pharmasset, Inc.,(Nasdaq: V...7128 in,combination with Pegasys (pegylated interf...nt-naive patients chronically infected with hepati...f PSI-6130, an oral cytidine,nucleoside analog pol...hrough Pharmasset,s collaboration with Roche. The ...
Other Medicine Technology:Cellectar Expands Clinical Management Team 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 2Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 3Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 4Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C 5
..., , The Shortyavailable with both Impact and Impac...-face relationship with the scientific community g... pipetting easier and more effective., Shorter a...., Gets you closer to the working area for more...
...Impact2 Pipettors , , Available with five differe...pact2 pipettors can effectively meet the demands o...mic design and superior functionality as our multi...program for a wide range of liquid handling tasks ...
...est value in high performance electronic pipetting...ght design reduce hand fatigue and strain, Stres..., Color coding for easy volume identification, A...se Hamilton AdvanTip Low Retention and AdvanTip Pr...
BioPette E Electronic Pipettor, 100-1000l
Medicine Products: